Contract Manufacturing Industry News

  1. Dr. Reddy’s Custom Pharmaceutical Services (CPS) Business Expands Its Manufacturing Operations In Mirfield, UK 10/8/2012

    The Custom Pharmaceutical Services (CPS) business of Dr. Reddy’s Laboratories Ltd. recently announced expansion in the areas of activated mPEG manufacturing and in the development and manufacture of NCE (New Chemical Entities) APIs for use in pre-clinical through to commercial development at its manufacturing facility in Mirfield, UK.

  2. ICON Partners With Korea National Enterprise For Clinical Trials 10/3/2012

    ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Korea National Enterprise for Clinical Trials (KoNECT) recently announced they have signed a  partnership agreement that aims to advance the clinical trials industry in South Korea.

  3. Recipharm Monts Secures Regulatory Approval From ANSM To Fill Biotech Products 9/17/2012

    Recipharm Monts, located near Tours (France), specialist in the manufacture of sterile products in glass containers, recently announced it has secured authorisation from the French health authorities (ANSM) to fill biotech products.

  4. Chiltern Welcomes Drs. Dieter Seitz-Tutter And Alexandra Adams 9/10/2012

    Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Drs. Dieter Seitz-Tutter and Alexandra Adams have joined Chiltern, bringing their extensive expertise in clinical research to serve our clients’ needs and to strengthen our Global Clinical Development service.

  5. Xcelience Expands Clinical Trial Supplies Manufacturing And Packaging 9/7/2012

    Xcelience, a leader in early drug development, has expanded clinical trial supplies manufacturing and packaging capabilities to include four new pieces of equipment and a new fully-automated packaging line.

  6. Aptuit SSCI To Hold Solid State Chemistry Short Course At The University Of Chicago 8/24/2012

    SSCI Inc., A Division of Aptuit, will be offering “Pharmaceutical Solids: Essential Knowledge and Advanced Concepts,” a two-day Pharmaceutical Solids Short Course for drug development scientists and related professionals.

  7. Industry And Academic Pros Attract More Than 150 Participants At Aptuit Science Day In Verona, Italy 8/24/2012

    Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, expressed appreciation to guests and presenters who participated in the second annual Science Day Event at The Aptuit Center for Drug Discovery & Development in Verona, Italy on May 16, 2012. “Once again, we were able to share a lively exchange of ideas in response to the insightful presentations delivered by distinguished members of the industry and academia,” he said.

  8. Almirall And Quintiles Sign Long-Term Commercial UK Partnership 7/30/2012

    Almirall and Quintiles have reached a long-term strategic partnership agreement to promote Almirall’s respiratory portfolio in the UK commencing with a new, long-acting antimuscarinic (LAMA) delivered via an innovative, multi-dose inhaler for the treatment of chronic obstructive pulmonary disease (COPD).

  9. Parexel Launches The Parexel Biopharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies 7/24/2012

     PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of the PAREXEL BioPharm Unit – a dedicated unit within PAREXEL focused solely on the unique needs of small and mid-sized biopharmaceutical companies to help them achieve their development goals.

  10. ScinoPharm to Provide Contract Manufacturing Services For VIVUS’ Newly-Approved Anti-Obesity Drug, Qsymia™ 7/24/2012

    ScinoPharm (TWSE:1789) announced today that its Tainan, Taiwan Facility will provide commercial manufacturing of topiramate active pharmaceutical ingredient (“API”) for VIVUS’ Qsymia™, a new drug for the treatment of obesity approved by the United States Food and Drug Administration on July 17, 2012.